Weekly CEO News from Richard Ingram
January 30, 2018

As you would expect, given how the last minutes in the US trading influences Asia – we opened lower. The Nikkei did attempt a small recovery just after the opening, but this was not to last and in-fact the selling

Read more

Eddie Ghabour, Co-Owner and Managing Partner at Key Advisors LLC, joins me to outline how rising yields impact the mentality and strategies for income investors. We also look at the health of the US markets in the face of the

Read more

Two days of selling has finally put a stop to the accelerated gains from December but it should also provide an opportunity to shake the weak hands out of their positions and set up a more sustainable rally. The nascent breakout

Read more

In the final stages of every market cycle, asset classes that have gone up on excess liquidity, leverage and speculative fervor, come down together all around the world. As screens of red in global financial markets attest this week, historic

Read more

Now that the short-term floor trader pivot panned out so well, what do we look at next? After 20 days of closing above S1, yesterday the S&P 500 closed below it. Today, it gapped below S1.  We have a confirmed

Read more

BTC/USD DAILY CHART (LOG) Technical Outlook: Earlier this month we documented the objective break of the January opening-range in Bitcoin prices as the decline was approaching initial support targets. We were looking, “for signs of a near-term exhaustion low in price for the

Read more

Stocks continued selling off overnight in the Asian and European markets, and US stocks followed the course scraping another layer of foam off the prices. Volume today was greater than the 20 day moving average. So this sell off had

Read more

One month ago today I pointed out the growing gap between the S&P 500 CAPE and the personal saving rate in the U.S. (see The ‘CAPE To Saving Rate’ Ratio Signals A Terrible 2018 For U.S. Stocks), a ratio which

Read more

For the first time since Dec 20th, The Dow dared to lose investors’ money for two days straight. This is the biggest two-day drop since September 2016. The culprits…? Video length: 00:00:29 Bear in mind that stocks are still on

Read more

Florida-based investment manager Polen Capital is bullish on Regeneron Pharmaceuticals Inc (Nasdaq:REGN), a New York-based biotech company with six FDA-approved medicines and numerous product candidates in a range of diseases, including asthma, pain, cancer and infectious diseases. Polen Capital discussed Regeneron Pharmaceuticals and

Read more